CLCN4 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.218200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.145000E-01
Normal-vs-Stage2
3.543200E-01
Normal-vs-Stage3
6.174200E-01
Normal-vs-Stage4
4.391200E-01
Stage1-vs-Stage2
3.640100E-02
Stage1-vs-Stage3
4.638200E-01
Stage1-vs-Stage4
3.845400E-01
Stage2-vs-Stage3
7.252000E-01
Stage2-vs-Stage4
8.912200E-01
Stage3-vs-Stage4
8.849800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.737800E-01
Normal-vs-AfricanAmerican
7.205600E-01
Normal-vs-Asian
7.810800E-01
Caucasian-vs-AfricanAmerican
2.636400E-01
Caucasian-vs-Asian
5.976800E-01
AfricanAmerican-vs-Asian
5.020600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.112800E-01
Normal-vs-Female
8.560800E-01
Male-vs-Female
5.259700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.978400E-01
Normal-vs-Age(41-60Yrs)
9.519600E-01
Normal-vs-Age(61-80Yrs)
4.686000E-01
Normal-vs-Age(81-100Yrs)
3.156500E-03
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.092600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
1.431770E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.702400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
5.438300E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
9.038500E-04
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.692000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.006000E-01
Normal-vs-Daily Drinker
3.938400E-01
Normal-vs-Weekly Drinker
1.097840E-01
Normal-vs-Occasional Drinker
6.827800E-01
Normal-vs-Social Drinker
7.656000E-01
Non Drinker-vs-Daily Drinker
8.928200E-01
Non Drinker-vs-Weekly Drinker
8.156400E-01
Non Drinker-vs-Occasional Drinker
1.673560E-01
Non Drinker-vs-Social Drinker
4.510200E-01
Daily Drinker-vs-Weekly Drinker
7.448800E-01
Daily Drinker-vs-Occasional Drinker
1.990010E-01
Daily Drinker-vs-Social Drinker
5.059000E-01
Weekly Drinker-vs-Occasional Drinker
1.364040E-01
Weekly Drinker-vs-Social Drinker
3.844400E-01
Occasional Drinker-vs-Social Drinker
6.044800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.822000E-01
Normal-vs-Grade 2
3.738600E-01
Normal-vs-Grade 3
3.668200E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
9.510000E-02
Grade 1-vs-Grade 3
5.407600E-02
Grade 1-vs-Grade 4
3.822000E-01
Grade 2-vs-Grade 3
5.071200E-01
Grade 2-vs-Grade 4
3.738600E-01
Grade 3-vs-Grade 4
3.668200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
6.347500E-02
Normal-vs-NonDiabetic
7.943800E-01
Diabetic-vs-NonDiabetic
2.401400E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.628200E-01
Normal-vs-NoPancreatitis
6.589600E-01
Pancreatitis-vs-NoPancreatitis
5.309000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.237400E-01
Normal-vs-N1
3.946000E-01
N0-vs-N1
1.439790E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.739400E-01
Normal-vs-TP53-NonMutant
9.269600E-01
TP53-Mutant-vs-TP53-NonMutant
1.371840E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
